Press Releases

Press Releases

Date Title
November 6, 2019
UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates
SAN FRANCISCO , Nov. 06, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today reported financial results for the third quarter ended September 30, 2019
October 31, 2019
UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee
SAN FRANCISCO , Oct. 31, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the first patient has been dosed in a Phase 2 study of UBX0101 in patients with
October 24, 2019
UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting
SAN FRANCISCO , Oct. 24, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that two abstracts summarizing recent studies on the role of
October 23, 2019
Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
SAN FRANCISCO , Oct. 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced it will report results for the third quarter ended September 30,
September 20, 2019
UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference
SAN FRANCISCO , Sept. 20, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate
August 27, 2019
UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
SAN FRANCISCO , Aug. 27, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate at
August 7, 2019
UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates
SAN FRANCISCO , Aug. 07, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today reported financial results for the second quarter ended June 30, 2019 .
July 30, 2019
UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee
SAN FRANCISCO , July 30, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced details for the planned Phase 2 study of UBX0101 in patients
July 30, 2019
UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results
SAN FRANCISCO , July 30, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, plans to report results for the second quarter ended June 30, 2019 , on
June 18, 2019
UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee
Clinical results support senescent cell elimination with UBX0101 as a potential treatment for osteoarthritis Topline results demonstrate a dose-dependent and clinically meaningful impact on pain Call with management scheduled for today at 8:00 a.m. EDT SAN FRANCISCO , June 18, 2019 (GLOBE NEWSWIRE)
Displaying 1 - 10 of 20